Dapazin

Ajanta Pharma Limited🇵🇭 Food and Drug Administration - Philippines

Approval Id: b79e10472875553a
Drug Approval Philippines Name: Dapazin
Product Name: Dapazin
Registration Number: DR-XY49139
Brand Name: Dapazin
Generic Name: Dapagliflozin
Dosage Form: Film-Coated Tablet
Dosage Strength: 10 mg
Manufacturer: Ajanta Pharma Limited
Importer: Ajanta Pharma Philippines Inc.
Distributor: Ajanta Pharma Philippines Inc.
Company Detail Path: /organization/ajanta-pharma-limited
Issuance Date: 26 July 2024
Expiry Date: 26 July 2029
Pharmacologic Category: Blood Glucose Lowering Drug (Sodium-glucose co-transporter 2 (SGLT2) inhibitor).
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

b79e10472875553a

Type

Standard